Qatari German Company for Medical Devices (Q.P.S.C.) (QGMD.QA)
QAR 1.42
(0.64%)
QAR 1.42
(0.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.58 Million | 1.04 Million | 6.96 Million | -15.95 Million | 1.93 Million | -1.33 Million |
| Net Income | 1.33 Million | 1.24 Million | 1.18 Million | 884.18 Thousand | -10.38 Million | -12.83 Million |
| Depreciation & Amortization | 5.35 Million | 5.43 Million | 5.41 Million | 5.48 Million | 5.53 Million | 5.7 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7.21 Million | -7.94 Million | -504.26 Thousand | -19.88 Million | 3.57 Million | -1.22 Million |
| Other non-cash items | -2.06 Million | 2.31 Million | 878.01 Thousand | -2.43 Million | 3.21 Million | 7.02 Million |
| Investing Cash Flow | -1.05 Million | -251.72 Thousand | -558.61 Thousand | -641.84 Thousand | -85.23 Thousand | -248.89 Thousand |
| Investments in PPE | -1.05 Million | -251.72 Thousand | -558.61 Thousand | -664.84 Thousand | -85.23 Thousand | -248.89 Thousand |
| Acquisitions | - | - | - | 23 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 23 Thousand | - | - |
| Financing Cash Flow | -2.58 Million | 359.11 Thousand | -4.25 Million | 18.66 Million | -3.11 Million | 2.96 Million |
| Debt repayment | -2.57 Million | -3.85 Million | -3.25 Million | -19.98 Million | -3.83 Million | -8.22 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -11.52 Thousand | 4.21 Million | -1 Million | 38.64 Million | 727.04 Thousand | 11.18 Million |
| Accounts receivables | -17.85 Million | -9.44 Million | -2.47 Million | -12.6 Million | 2.67 Million | 214.19 Thousand |
| Accounts payables | 7.96 Million | 2.01 Million | 5.33 Million | 3.87 Million | 21.8 Thousand | -1.66 Million |
| Inventory | 2.85 Million | -517.36 Thousand | -3.36 Million | -11.15 Million | 877.41 Thousand | 221.48 Thousand |
| Other working capital | -173.56 Thousand | 1.00 | -104.21 Thousand | -189.86 Thousand | -229.92 Thousand | -1.44 Million |
| Cash at beginning of period | 6.34 Million | 5.19 Million | 3.03 Million | 961.9 Thousand | -12.92 Million | -14.3 Million |
| Cash at end of period | 119.89 Thousand | 6.34 Million | 5.19 Million | 3.03 Million | -14.19 Million | -12.92 Million |
| Capital Expenditure | -1.05 Million | -251.72 Thousand | -558.61 Thousand | -664.84 Thousand | -85.23 Thousand | -248.89 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -6.22 Million | 1.15 Million | 2.15 Million | 2.07 Million | -1.26 Million | 1.37 Million |
| Free Cash Flow | -3.64 Million | 795.74 Thousand | 6.4 Million | -16.61 Million | 1.84 Million | -1.58 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 577.39 Thousand | 284.44 Thousand | 1.16 Million | 1.33 Million | -1.38 Million | 1.29 Million |
| Depreciation & Amortization | - | - | 1.33 Million | 5.35 Million | 1.32 Million | 1.34 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -7.21 Million | - | -7.62 Million |
| Other non-cash items | -577.39 Thousand | -284.44 Thousand | -1.16 Million | -2.06 Million | 1.38 Million | -1.29 Million |
| Investing Cash Flow | - | - | - | -1.05 Million | - | -432.94 Thousand |
| Investments in PPE | - | - | - | -1.05 Million | - | -432.94 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | -2.58 Million | - | -507.33 Thousand |
| Debt repayment | - | - | - | -2.57 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -11.52 Thousand | - | -507.33 Thousand |
| Accounts receivables | - | - | - | -17.85 Million | - | -10.01 Million |
| Accounts payables | - | - | - | 7.96 Million | - | - |
| Inventory | - | - | - | 2.85 Million | - | 2.39 Million |
| Other working capital | - | - | - | -173.56 Thousand | - | - |
| Cash at beginning of period | - | - | 110.88 Thousand | 6.34 Million | 414.72 Thousand | 438 Thousand |
| Cash at end of period | - | - | 119.89 Thousand | 119.89 Thousand | 110.88 Thousand | 414.72 Thousand |
| Capital Expenditure | - | - | - | -1.05 Million | - | -432.94 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | 2.94 Million |
| Net cash flow / Change in cash | - | - | 9007.00 | -6.22 Million | -303.84 Thousand | -23.27 Thousand |
| Free Cash Flow | - | - | 2.66 Million | -3.64 Million | 2.64 Million | -2.45 Million |
CTOWY
036830
AMAT
ADHI
SUMEETINDS
286940